Avid Bioservices Inc (CDMO)

[BioBS2012]

.......I am praying they are not being so bold as to think they can go it alone.

Paul Lytle from the recent CC seems to have a different view point...

.......We have our bavituximab program, which is a I/O compound in Phase 3 development that we own the 100% of the rights to. That brings tremendous partnering opportunities to the table. And that’s one of our goals here internally is to partner ex-U.S. and to drive the value here in the U.S. for ourselves. So, I think we are going to be looking at lot of those things to kind of balance our financial resources and these are just a couple of sources that we have available to us that not all companies have.